DrugBiological
Enamel matrix proteins clinical trials
Keep track of what changes. Save the enamel matrix proteins studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2019 (2)
| Year | Studies |
|---|---|
| 2009 | 1 |
| 2013 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 7
University of Campinas, Brazil (2) · University of Oslo (2) · University of Nebraska (1) · University of Sao Paulo (1) · Mansoura University (1)
Often tested with
Tested in the same studies.
Hydroxyapatite-beta tricalcium phosphate (2)
Studies
Open first, then newest update. How each study uses enamel matrix proteins is read from its arms, and is right about nine times in ten.
Testing it · 7
- Evaluation of Enamel Matrix Derivative in Immediate Dental Implants in the Mandibular Molar RegionRecruitingNot applicableMansoura UniversityNCT07727655Written as Enamel Matrix Derivative (Emdogain)
- Effect of Enamel Matrix Proteins on Clinical Attachment Level and Alveolar Bone in Periodontal Maintenance PatientsCompletedEarly Phase 1University of NebraskaNCT02972788Written as Enamel Matrix Proteins Derivative
- Mandibular Furcation III Regeneration (FURC-III-REGEN)TerminatedPhase 4University of OsloNCT04059458Written as Biphasic calcium phosphate (Straumann Bone Ceramic) + enamel matrix proteins (Straumann Emdogain)
- Mandibular Furcation II RegenerationTerminatedPhase 4University of OsloNCT04059445Written as Biphasic calcium phosphate (Straumann Bone Ceramic) + enamel matrix proteins (Straumann Emdogain)
- Enamel Matrix Proteins in the Treatment of Intrabony Defects in Patients With Aggressive and Chronic PeriodontitisCompletedPhase 4University of Campinas, BrazilNCT03025204Written as Enamel Matrix Proteins
- EMD and/or Bone Substitute for the Treatment of Class II FurcationsCompletedPhase 4University of Campinas, BrazilNCT02474498Written as EMD
- Root Coverage in Smokers With Acellular Dermal Matrix Graft and Enamel Matrix DerivativeCompletedPhase 2University of Sao PauloNCT02135471Written as enamel matrix derivative
As the comparator · 2 — what is tested is compared with enamel matrix proteins
- PRF Versus Emdogain for Class II Furcation Defects of Mandibular MolarsCompletedNot applicableMedical University of SofiaNCT07841301Written as Emdogain
- Comparison of Clinical and Radiographic Parameters in the Application of Cross-linked Hyaluronic Acid 1.8% and Enamel Matrix Derivative in Periodontal Regeneration.CompletedPhase 4Andres Lopez RoldanNCT04274244Written as Enamel Matrix Proteins (Active comparator group)
Codes
What other systems call enamel matrix proteins · ClinicalTrials.gg INT004027
- MeSH (NLM) C109069enamel matrix proteinsOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C109069 | enamel matrix proteins | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.